$10.00
-0.22 (-2.10%)
Open$10.22
Previous Close$10.22
Day High$10.43
Day Low$9.94
52W High$11.66
52W Low$4.16
Volume—
Avg Volume1.52M
Market Cap1.49B
P/E Ratio—
EPS$-3.16
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+69.8% upside
Current
$10.00
$10.00
Target
$16.98
$16.98
$13.41
$16.98 avg
$22.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 73.97M | 212.07M | 113.39M |
| Net Income | -472,590,158 | -1,219,412,678 | -30,823,495 |
| Profit Margin | -638.9% | -606.9% | -27.2% |
| EBITDA | -517,205,156 | -1,408,672,299 | -42,153,177 |
| Free Cash Flow | — | — | -22,930,380 |
| Rev Growth | -65.1% | -65.1% | +24.3% |
| Debt/Equity | — | — | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |